CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangzhou LBP Medicine Scnc&Tech Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangzhou LBP Medicine Scnc&Tech Co Ltd
No. 2, Kexin Street, Fengxin Road
Science City, Huangpu District
Phone: +86 2032210051p:+86 2032210051 GUANGZHOU, GNG  510663  China Ticker: 688393688393
Business Summary
Guangzhou LBP Medicine Science & Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments. The Company's main business focuses on tumor screening and precision diagnosis, and the application department is mainly pathology. The Company provides a series of tumor screening and diagnostic reagents, automated equipment and auxiliary diagnosis artificial intelligence software. The Company also provides multiple operating models for the construction of specialized alliance pathology diagnosis centers, grassroots pathology departments, and cervical cancer intelligent screening centers, and is equipped with pathology equipment, reagents and consumables, digital and artificial intelligence products, diagnostic services, and technical support. The Company mainly operates its businesses in the domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager XiangtingCai 62 3/17/2014 3/17/2014
Chief Financial Officer QuannengHou 42 5/16/2022 5/16/2022
Chief Human Resources Officer, Staff Elected Director JingZeng 44 10/27/2025 5/1/2023
7 additional Officers and Directors records available in full report.

General Information
Number of Employees: 768 (As of 12/31/2025)
Outstanding Shares: 93,567,699 (As of 3/31/2026)
Shareholders: 8,266
Stock Exchange: SHA
Fax Number: +86 2032290284


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, July 1, 2026